1. Home
  2. NBIX vs WSO Comparison

NBIX vs WSO Comparison

Compare NBIX & WSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$163.88

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Logo Watsco Inc.

WSO

Watsco Inc.

HOLD

Current Price

$371.38

Market Cap

14.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBIX
WSO
Founded
1992
1945
Country
United States
United States
Employees
N/A
7050
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Industrial Machinery/Components
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
14.9B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
NBIX
WSO
Price
$163.88
$371.38
Analyst Decision
Strong Buy
Hold
Analyst Count
22
6
Target Price
$180.91
$399.00
AVG Volume (30 Days)
1.1M
306.3K
Earning Date
05-05-2026
04-28-2026
Dividend Yield
N/A
3.08%
EPS Growth
41.95
N/A
EPS
1.91
N/A
Revenue
$161,626,000.00
N/A
Revenue This Year
$24.73
$3.02
Revenue Next Year
$13.14
$5.20
P/E Ratio
$87.58
$34.24
Revenue Growth
977.51
N/A
52 Week Low
$122.14
$323.05
52 Week High
$169.57
$494.94

Technical Indicators

Market Signals
Indicator
NBIX
WSO
Relative Strength Index (RSI) 65.15 37.42
Support Level $134.92 $355.10
Resistance Level N/A $388.96
Average True Range (ATR) 4.51 11.59
MACD 0.13 -1.65
Stochastic Oscillator 67.18 26.52

Price Performance

Historical Comparison
NBIX
WSO

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

About WSO Watsco Inc.

Watsco is the largest HVAC and refrigeration products distributor in North America with approximately 13% market share. The company primarily operates in the United States (90% of revenue) with significant exposure in the Sunbelt states. Watsco also has operations in Canada, Latin America, and the Caribbean. The company's customer base comprises more than 120,000 dealers and contractors serving the replacement and new-construction HVAC/R markets for residential and light-commercial applications. As much as 20% of residential HVAC units are distributed through Watsco in any given year. Revenue is approximately 75%-80% residential HVAC and 20%-25% commercial, with relatively small exposure to more complex "applied" solutions.

Share on Social Networks: